This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of Tennessee Research Foundation. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: The Innovative Contributions of Jianjun Qi
Introduction
Jianjun Qi is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tuberculosis agents. With a total of 2 patents, his work is recognized for its potential impact on treating serious infections.
Latest Patents
Among his latest patents, Jianjun Qi has developed novel 3'-deoxy-3′-acylaminospectinomycin compounds. These compounds are described as effective anti-tuberculosis agents. Additionally, he has outlined methods for using these compounds and other spectinomycin analogs in treating tuberculosis and microbial infections.
Career Highlights
Jianjun Qi is affiliated with the University of Tennessee Research Foundation, where he continues to advance his research. His work is characterized by a commitment to addressing critical health challenges through innovative solutions.
Collaborations
He has collaborated with esteemed colleagues such as Richard Edward Lee and Julian G Hurdle, contributing to a dynamic research environment focused on impactful medical advancements.
Conclusion
Jianjun Qi's innovative work in developing anti-tuberculosis agents showcases his dedication to improving public health. His contributions are vital in the ongoing fight against infectious diseases.